Effects of Dose and Route of Administration on Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine in the Rat

Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans

Rafael de la Torre, Magı́ Farré, Jordi Ortuño et al. · British Journal of Clinical Pharmacology · 2000 · 407 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans

Marta Más, Magí Farré, Rafael de la Torre et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 362 citations

Medicine, Pharmacokinetics, Pharmacology +13

Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

Michael P. Johnson, Andrew J. Hoffman, David E. Nichols · European Journal of Pharmacology · 1986 · 307 citations

Medicine, Neuroscience, Pharmacology +12

3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro

Vincent Setola, Sandra J. Hufeisen, K. Jane Grande‐Allen et al. · Molecular Pharmacology · 2003 · 301 citations · Full text

Medicine, Pharmacology, Psychiatry +17

The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6)

Geoffrey T. Tucker, M. S. Lennard, S. W. Ellis et al. · Biochemical Pharmacology · 1994 · 236 citations

Medicine, Pharmacology, Toxicology +12